These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6120886)
1. [Effects of ranitidine, a new histamine H2-receptor antagonist, on histamine- and aspirin-induced gastric ulcers in rats and dogs (author's transl)]. Okabe S; Tabata K; Ohtsuki H Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):549-55. PubMed ID: 6120886 [TBL] [Abstract][Full Text] [Related]
2. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)]. Okabe S; Kunimi H; Ohtsuki H Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654 [TBL] [Abstract][Full Text] [Related]
3. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities. Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106 [TBL] [Abstract][Full Text] [Related]
4. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)]. Ohtsuki H; Okabe S Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885 [TBL] [Abstract][Full Text] [Related]
5. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs]. Okabe S; Nishida T; Igata H; Takagi K Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370 [TBL] [Abstract][Full Text] [Related]
6. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)]. Okabe S; Kawakami M Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281 [TBL] [Abstract][Full Text] [Related]
7. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist. Brittain RT; Daly MJ Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770 [TBL] [Abstract][Full Text] [Related]
8. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. Konturek SJ; Kwiecień N; Obtułowicz W; Polański M; Kopp B; Oleksy J Gut; 1983 Feb; 24(2):89-93. PubMed ID: 6133815 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist. Helman CA; Tim LO Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952 [TBL] [Abstract][Full Text] [Related]
10. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine]. Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267 [TBL] [Abstract][Full Text] [Related]
11. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers. Okabe S; Takeuchi K; Urushidani T; Takagi K Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007 [TBL] [Abstract][Full Text] [Related]
12. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog. Daly MJ; Humphray JM; Stables R Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035 [TBL] [Abstract][Full Text] [Related]
13. H2-receptor antagonists protect against aspirin-induced gastric lesions in the rat. Bunce KT; Daly MJ; Humphray JM; Stables R Agents Actions; 1981 Apr; 11(1-2):167-70. PubMed ID: 6113744 [TBL] [Abstract][Full Text] [Related]
14. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216 [TBL] [Abstract][Full Text] [Related]
15. [Ranitidine, a new histamine H2 receptor antagonist. First experimental and clinical data]. Simon B; Dammann HG; Müller P; Kather H Minerva Med; 1981 Oct; 72(40):2657-61. PubMed ID: 6117040 [TBL] [Abstract][Full Text] [Related]
16. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine. Cavanagh RL; Usakewicz JJ; Buyniski JP J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316 [TBL] [Abstract][Full Text] [Related]
17. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog. Cavanagh RL; Buyniski JP Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine. Katz LB; Scott CK; Shriver DA J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172 [TBL] [Abstract][Full Text] [Related]
19. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models. Del Soldato P; Ghiorzi A; Cereda E; Donetti A Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110 [TBL] [Abstract][Full Text] [Related]
20. Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor. Satoh H; Asano S; Maeda R; Murakami I; Inada I; Sato F; Shino A Jpn J Pharmacol; 1997 Mar; 73(3):229-41. PubMed ID: 9127818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]